Opinion|Videos|July 23, 2024

Combining In-Office and At-Home Therapies

Author(s)Jessilin Quint, OD, MBA, MS, FAAO, Selina R. McGee, OD, FAAO, Dipl ABO

Dry eye experts provide comprehensive insights on the role of in-office procedural therapies.

Episodes in this series

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 1 Overview of MGD and Its Causes

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 2 Differentiating Aqueous vs Evaporative Dry Eye

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 3 Long-Term Consequences of Untreated MGD

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 4 Factors to Consider in Treatment Selection for MGD

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 5 Managing Evaporative Dry Eye with New FDA-Approved Therapy

Selina McGee, OD, FAAO, and Jessilin Quint, OD, MBA, FAAO

EP. 6 Differentiating Between the Semi-Fluorinated Alkane-Based Therapies for Dry Eye

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO

EP. 7 Combining In-Office and At-Home Therapies

Jessilin Quint, OD, MBA, FAAO, and Selina McGee, OD, FAAO

EP. 8 Clinical Case Scenario: Management Strategies for MGD and Key Takeaways

Video content above is prompted by the following questions:

When do you reach for procedural therapies for meibomian gland dysfunction (MGD)? What in-office procedural therapies do you use for MGD?

Newsletter

Want more insights like this? Subscribe to Optometry Times and get clinical pearls and practice tips delivered straight to your inbox.

Related Content

Takeaways from this week in optometry | Image Credit: Canva

Takeaways from this week in optometry: August 31-September 4

September 5th 2026

Closeup of older woman's irritated eye Image credit: AdobeStock/Hector

Survey: Fewer than 1 in 7 women link dry eye to perimenopause or menopause

ByLucia Gambuzza

September 3rd 2026

Work productivity | Image Credit: Adobe Stock/Prostock-studio

Study: Tryptyr treatment associated with complex visual tasks improvement in DED patients

September 2nd 2026

Takeaways from this week in optometry | Image Credit: Canva

Takeaways from this week in optometry: August 24-28

August 29th 2026

Yehia Hashad, MD, executive vice president of research and development and chief medical officer at Bausch + Lomb (Credit: Bausch + Lomb)

Bausch + Lomb advances 2 first-in-class eye health therapies

August 25th 2026

Latest CME

EyeCon 2026

EyeCon 2026

September 26, 2026

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - NYC Metro

Deep Parikh, MD

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - California

Dilsher S. Dhoot, MD, FASRS

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

When Mites Meet Their Match: Empowering Patients With Targeted Treatment for 𝘋𝘦𝘮𝘰𝘥𝘦𝘹 Blepharitis

Mile Brujic, OD, FAAO; Pierce Kenworthy, OD, FAAO; Blair Lonsberry, MS, OD, MEd, FAAO

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

The Presbyopia-Correcting and Toric IOL Playbook: Game-Changing Surgical Strategies to Enhance Patient Outcomes

Uday Devgan, MD, FACS, FRCS

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Bridging Regional Challenges in Retinal Disease Management: Applying Advanced Anti-VEGF Therapy in Community Practice - Florida

Carl J. Danzig, MD, FASRS

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

(CME) The Truth About Presbyopia Drops: Evidence-Based Cases and Myth-Busting Insights

Damon Dierker, OD FAAO; Maria Pribis, OD

Trending on Optometry Times - Clinical News & Expert Optometrist Insights

Takeaways from this week in optometry: August 31-September 4

DOT spectacle lens wear count ascends to 2 million pairs worldwide

Survey: Fewer than 1 in 7 women link dry eye to perimenopause or menopause

Study: Tryptyr treatment associated with complex visual tasks improvement in DED patients

FDA grants De Novo nod to Avulux lens for migraine-associated photophobia